Showing results (91-100 of 340) with videos related to

Sort By:
Pageof 34
European Journal of Heart Failure|March 20, 2003
Endothelial dysfunction and infarct-size relate to impaired EDHF response in rat experimental chronic heart failureSimone Gschwend, Hendrik Buikema, Robert H Henning, et al.
Current Hypertension Reports|September 15, 2005
Microalbuminuria and C-reactive protein: similar messengers of cardiovascular risk?Stephan J L Bakker, Ron T Gansevoort, Erik M Stuveling, et al.
Journal of Nephrology|July 29, 2006
Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic responsePeter Ochodnicky, Simone Vettoretti, Robert H Henning, et al.
Journal of the American Society of Nephrology : JASN|June 6, 2008
Extended prognostic value of urinary albumin excretion for cardiovascular eventsAuke H Brantsma, Stephan J L Bakker, Dick de Zeeuw, et al.
American Journal of Physiology. Renal Physiology|February 26, 2016
Renal endothelial function is associated with the anti-proteinuric effect of ACE inhibition in 5/6 nephrectomized ratsSimone Vettoretti, Peter Vavrinec, Peter Ochodnicky, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 6, 2018
Proteinuria and cholesterol reduction are independently associated with less renal function decline in statin-treated patients; a post hoc analysis of the PLANET trialsNienke M A Idzerda, Michelle J Pena, Hans-Henrik Parving, et al.
Journal of Hypertension|February 22, 2013
High-sensitivity troponin T predicts worsening of albuminuria in hypertension; results of a nested case-control study with confirmation in diabetesMerel E Hellemons, Hiddo J Lambers Heerspink, Ron T Gansevoort, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 11, 2014
Predictors of congestive heart failure after treatment with an endothelin receptor antagonistJamo Hoekman, Hiddo J Lambers Heerspink, Giancarlo Viberti, et al.
Drug Safety|April 5, 2013
Development and Initial Validation of a Patient-Reported Adverse Drug Event QuestionnaireSieta T de Vries, Peter G M Mol, Dick de Zeeuw, et al.
Pageof 34